Day-4 Myeloid Dendritic Cells Pulsed with Whole Tumor Lysate Are Highly Immunogenic and Elicit Potent Anti-Tumor Responses

“Day-7” myeloid DCs are commonly used in the clinic. However, there is a strong need to develop DCs faster that have the same potent immunostimulatory capacity as “Day-7” myeloid DCs and at the same time minimizing time, labor and cost of DC preparations. Although “2 days” DCs can elicit peptide-spe...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiang, Cheryl Lai-Lai, Hagemann, Andrea R., Leskowitz, Rachel, Mick, Rosemarie, Garrabrant, Thomas, Czerniecki, Brian J., Kandalaft, Lana E., Powell, Daniel J., Coukos, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237492/
https://www.ncbi.nlm.nih.gov/pubmed/22194898
http://dx.doi.org/10.1371/journal.pone.0028732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237492/
https://www.ncbi.nlm.nih.gov/pubmed/22194898
http://dx.doi.org/10.1371/journal.pone.0028732

Ejemplares similares